In The News Posted June 16, 2021 Share Posted June 16, 2021 The company is building a platform to achieve unlimited cannabis bioproduct candidates by combining proprietary gene editing, synthetic biotechnology, and optimized drug development processes LEXINGTON, Ky., June 16, 2021 /PRNewswire/ -- Demeetra AgBio, Inc., a pre-clinical therapeutics...View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.